Aim: The aim of this study was to evaluate the anti-hypertensive efficacy of a fixed-dose combination (FDC) of Efonidipine 40 mg and Telmisartan 40 mg in Stage II hypertensive patients. Study Design: Multicentric, randomized, double-blind, parallel, comparative Phase III clinica...
Open access
Research Article10.9734/ca/2023/v12i1309
Aim: To evaluate the antihypertensive efficacy and safety of the fixed-dose combination (FDC) of Efonidipine and S (-) Metoprolol in adult patients with hypertension. Study Design: Multicentric, double-blind, randomized, parallel, comparative Phase III trial. Methodology: This cl...
Open access
Research Article10.9734/ca/2022/v11i4300
Aim: This study aimed at evaluating the efficacy and safety of a fixed-dose combination (FDC) of Efonidipine and Chlorthalidone in a randomized, Phase III trial setting. Study Design: Multicentric, randomized, double-blind, parallel, comparative, active-controlled Phase III. Plac...
Aim: This study is aimed at evaluating the efficacy and safety of Intravenous Glutathione in moderate COVID-19 patients with respiratory distress. Study Design: A randomized, multicentric, double-blind, placebo-controlled, comparative Phase III clinical trial. Place and Duration...
Open access
Research Article10.9734/jammr/2022/v34i2231583
Aims: To assess the efficacy and fetomaternal safety of atosiban among Indian pregnant women presenting with preterm labor. Study Design: Prospective, open-label, multicentric, non-comparative, phase-IV clinical study. Place and Duration of Study: Department of Obstetrics and Gyn...
Open access
Research Article10.9734/jammr/2020/v32i2430754